These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 18042736)

  • 1. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral chemokines: intracellular life of recombinant C-C chemokine RANTES.
    Owais M; Arya SK
    J Hum Virol; 1999; 2(5):270-82. PubMed ID: 10551733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2.
    Nicholls DJ; Tomkinson NP; Wiley KE; Brammall A; Bowers L; Grahames C; Gaw A; Meghani P; Shelton P; Wright TJ; Mallinder PR
    Mol Pharmacol; 2008 Nov; 74(5):1193-202. PubMed ID: 18676678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.
    Haworth B; Lin H; Fidock M; Dorr P; Strange PG
    Biochem Pharmacol; 2007 Sep; 74(6):891-7. PubMed ID: 17669370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of amino acid residues crucial for chemokine receptor dimerization.
    Hernanz-Falcón P; Rodríguez-Frade JM; Serrano A; Juan D; del Sol A; Soriano SF; Roncal F; Gómez L; Valencia A; Martínez-A C; Mellado M
    Nat Immunol; 2004 Feb; 5(2):216-23. PubMed ID: 14716309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH; Tebben AJ
    Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.
    Maeda K; Nakata H; Koh Y; Miyakawa T; Ogata H; Takaoka Y; Shibayama S; Sagawa K; Fukushima D; Moravek J; Koyanagi Y; Mitsuya H
    J Virol; 2004 Aug; 78(16):8654-62. PubMed ID: 15280474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
    Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
    Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of specific intracellular domains of the human ETA receptor required for ligand binding and signal transduction.
    Hashido K; Adachi M; Gamou T; Watanabe T; Furuichi Y; Miyamoto C
    Cell Mol Biol Res; 1993; 39(1):3-12. PubMed ID: 8287069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists.
    Kondru R; Zhang J; Ji C; Mirzadegan T; Rotstein D; Sankuratri S; Dioszegi M
    Mol Pharmacol; 2008 Mar; 73(3):789-800. PubMed ID: 18096812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin.
    Springael JY; de Poorter C; Deupi X; Van Durme J; Pardo L; Parmentier M
    Cell Signal; 2007 Jul; 19(7):1446-56. PubMed ID: 17320349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice.
    Nakagami Y; Kawashima K; Yonekubo K; Etori M; Jojima T; Miyazaki S; Sawamura R; Hirahara K; Nara F; Yamashita M
    Eur J Pharmacol; 2009 Dec; 624(1-3):38-44. PubMed ID: 19818758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.
    Ajram L; Begg M; Slack R; Cryan J; Hall D; Hodgson S; Ford A; Barnes A; Swieboda D; Mousnier A; Solari R
    Eur J Pharmacol; 2014 Apr; 729(100):75-85. PubMed ID: 24534492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of CC chemokine receptor 5-binding peptide from a phage display peptide library.
    Wang FY; Zhang TY; Luo JX; He GA; Gu QL; Xiao F
    Biosci Biotechnol Biochem; 2006 Sep; 70(9):2035-41. PubMed ID: 16960395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.
    Bodart V; Anastassov V; Darkes MC; Idzan SR; Labrecque J; Lau G; Mosi RM; Neff KS; Nelson KL; Ruzek MC; Patel K; Santucci Z; Scarborough R; Wong RS; Bridger GJ; Macfarland RT; Fricker SP
    Biochem Pharmacol; 2009 Oct; 78(8):993-1000. PubMed ID: 19540208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the interactions between lactam analogs and the N-terminal extracellular tail of CC chemokine receptor 4 by CZE.
    Sun Z; Ling X; Sun W; Xiao J; Yin C; Wang Y
    Electrophoresis; 2007 Aug; 28(17):3064-9. PubMed ID: 17668450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
    Fukuda J; Suzuki G; Kimura T; Nagatomi Y; Ito S; Kawamoto H; Ozaki S; Ohta H
    Neuropharmacology; 2009 Sep; 57(4):438-45. PubMed ID: 19559036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors.
    Dong M; Pinon DI; Asmann YW; Miller LJ
    Mol Pharmacol; 2006 Jul; 70(1):206-13. PubMed ID: 16531505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.